| abstract |
The present invention relates to an oral mucosa pharmaceutical dosage form in wafer form. The wafer comprises a porous, hygroscopic mucoadhesive polymer matrix and at least one desired pharmaceutically active compound added thereto. The polymer is selected from a number of polymers with different dissolution rates and in use when taken orally, the matrix adheres to the oral mucosal surface and dissolves over time to release the pharmaceutically active compound. . The invention also relates to a method for producing a oral form of oral mucosa pharmaceutical dosage form, including freeze-drying or freeze-drying. |